FDMT. – 4D Molecular Therapeutics Inc
4D Molecular Therapeutics, Inc.FDMT
$7.50Name : 4D Molecular Therapeutics, Inc.
Sector : Healthcare
Industry: Biotechnology
Mark. Cap: $428,513,056.00
EPSttm : -3.75
4D Molecular Therapeutics, Inc.
$7.50
1.06%$0.08Float Short %
9.66
Margin Of Safety %
Put/Call OI Ratio
0.11
EPS Next Q Diff
-1.26
EPS Last/This Y
-0.28
EPS This/Next Y
-0.22
Price
7.48
Target Price
33.11
Analyst Recom
1.45
Performance Q
-14.09
Relative Volume
0.8
Beta
2.96
Ticker: FDMT
of 1
| Date | Symbol | Latest | P/C OI | P/C Vol | Total OI |
|---|---|---|---|---|---|
| 2025-12-02 | FDMT | 10.12 | 0.20 | 0.00 | 3689 |
| 2025-12-03 | FDMT | 10.68 | 0.20 | 1.82 | 3731 |
| 2025-12-04 | FDMT | 11.2 | 0.20 | 0.00 | 3738 |
| 2025-12-05 | FDMT | 10.69 | 0.20 | 0.02 | 3792 |
| 2025-12-08 | FDMT | 11.1 | 0.20 | 0.02 | 3757 |
| 2025-12-09 | FDMT | 10.5 | 0.19 | 0.00 | 3840 |
| 2025-12-10 | FDMT | 10.85 | 0.19 | 0.87 | 3841 |
| 2025-12-11 | FDMT | 10.92 | 0.20 | 0.00 | 3884 |
| 2025-12-12 | FDMT | 10.85 | 0.20 | 0.00 | 3896 |
| 2025-12-15 | FDMT | 10.95 | 0.20 | 0.00 | 3894 |
| 2025-12-16 | FDMT | 11.52 | 0.19 | 0.01 | 4080 |
| 2025-12-17 | FDMT | 9.2 | 0.19 | 1.17 | 4141 |
| 2025-12-18 | FDMT | 8.69 | 0.31 | 0.10 | 4690 |
| 2025-12-19 | FDMT | 8.68 | 0.30 | 0.02 | 4760 |
| 2025-12-22 | FDMT | 8.69 | 0.08 | 0.00 | 4325 |
| 2025-12-23 | FDMT | 7.88 | 0.08 | 0.78 | 4440 |
| 2025-12-26 | FDMT | 7.97 | 0.11 | 0.00 | 4726 |
| 2025-12-29 | FDMT | 7.67 | 0.11 | 0.00 | 4744 |
| 2025-12-30 | FDMT | 7.58 | 0.11 | 0.20 | 4752 |
| 2025-12-31 | FDMT | 7.48 | 0.11 | 160.00 | 4761 |
| Date | Symbol | Latest | P/C OI | P/C Vol | Total OI |
Current Page1 of 1
of 1
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
|---|---|---|---|---|---|
| 2025-12-02 | FDMT | 10.13 | 41.3 | - | -3.26 |
| 2025-12-03 | FDMT | 10.70 | 41.3 | - | -3.26 |
| 2025-12-04 | FDMT | 11.21 | 41.3 | - | -3.26 |
| 2025-12-05 | FDMT | 10.70 | 41.3 | - | -3.26 |
| 2025-12-08 | FDMT | 11.08 | 41.3 | - | -3.26 |
| 2025-12-09 | FDMT | 10.51 | 41.3 | - | -3.26 |
| 2025-12-10 | FDMT | 10.85 | 41.3 | - | -3.26 |
| 2025-12-11 | FDMT | 10.93 | 41.3 | - | -3.26 |
| 2025-12-12 | FDMT | 10.85 | 41.3 | - | -3.26 |
| 2025-12-15 | FDMT | 10.95 | 41.3 | - | -3.26 |
| 2025-12-16 | FDMT | 10.95 | 41.3 | - | -3.26 |
| 2025-12-17 | FDMT | 9.19 | 41.3 | - | -3.26 |
| 2025-12-18 | FDMT | 8.68 | 41.3 | - | -3.26 |
| 2025-12-19 | FDMT | 8.66 | 41.3 | - | -3.26 |
| 2025-12-22 | FDMT | 8.71 | 41.3 | - | -3.26 |
| 2025-12-23 | FDMT | 7.90 | 41.3 | - | -3.26 |
| 2025-12-26 | FDMT | 7.98 | 41.3 | - | -3.26 |
| 2025-12-29 | FDMT | 7.67 | 41.3 | - | -3.26 |
| 2025-12-30 | FDMT | 7.60 | 41.3 | - | -3.26 |
| 2025-12-31 | FDMT | 7.48 | 41.3 | - | -3.26 |
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
Current Page1 of 1
of 1
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
|---|---|---|---|---|
| 2025-12-02 | FDMT | -0.17 | -1.52 | 10.20 |
| 2025-12-03 | FDMT | -0.17 | -1.52 | 10.20 |
| 2025-12-04 | FDMT | -0.17 | -1.52 | 10.20 |
| 2025-12-05 | FDMT | -0.17 | -1.52 | 10.20 |
| 2025-12-08 | FDMT | -0.17 | -1.52 | 10.20 |
| 2025-12-09 | FDMT | -0.17 | -1.52 | 10.20 |
| 2025-12-10 | FDMT | -0.17 | -1.52 | 9.92 |
| 2025-12-11 | FDMT | -0.17 | -1.52 | 9.92 |
| 2025-12-12 | FDMT | -0.17 | -1.52 | 9.71 |
| 2025-12-15 | FDMT | -0.21 | -1.48 | 9.71 |
| 2025-12-16 | FDMT | -0.21 | -1.48 | 9.71 |
| 2025-12-17 | FDMT | -0.21 | -1.48 | 9.71 |
| 2025-12-18 | FDMT | -0.21 | -1.48 | 9.71 |
| 2025-12-19 | FDMT | -0.24 | -1.48 | 9.71 |
| 2025-12-22 | FDMT | -0.24 | -1.48 | 9.71 |
| 2025-12-23 | FDMT | -0.24 | -1.48 | 9.71 |
| 2025-12-26 | FDMT | -0.25 | -1.48 | 9.66 |
| 2025-12-29 | FDMT | -0.25 | -1.48 | 9.66 |
| 2025-12-30 | FDMT | -0.25 | -1.48 | 9.66 |
| 2025-12-31 | FDMT | -0.25 | -1.48 | 9.66 |
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
Current Page1 of 1
Last Quarter Act. EPS
0.33
Avg. EPS Est. Current Quarter
-0.53
Avg. EPS Est. Next Quarter
-0.93
Insider Transactions
-0.25
Institutional Transactions
-1.48
Beta
2.96
Average Sales Estimate Current Quarter
30
Average Sales Estimate Next Quarter
5
Fair Value
Quality Score
16
Growth Score
26
Sentiment Score
42
Actual DrawDown %
86.4
Max Drawdown 5-Year %
-95.2
Target Price
33.11
P/E
Forward P/E
PEG
P/S
3570.91
P/B
0.95
P/Free Cash Flow
EPS
-3.94
Average EPS Est. Cur. Y
-3.26
EPS Next Y. (Est.)
-3.48
Target Price Estimates Raised
Target Price Estimates Lowered
Profit Margin
-174314.17
Relative Volume
0.8
Return on Equity vs Sector %
-84
Return on Equity vs Industry %
-68.6
EPS 1 7Days Diff
EPS 1 30Days Diff
EBIT Estimation
4D Molecular Therapeutics, Inc.Sector: Healthcare
Industry: Biotechnology
Employees: 227
4D Molecular Therapeutics, Inc., a late-stage biotechnology company, engages in the development of adeno-associated virus vectors from its proprietary synthetic vector discovery platform, Therapeutic Vector Evolution in the Netherlands and the United States. Its lead product candidate is 4D-150 for the treatment of retinal vascular diseases by providing multi-year sustained production of anti-VEGF from the retina with intravitreal injection, as well as for treating wet age-related macular degeneration and diabetic macular edema. The company is also developing 4D-710, which is in early-stage study for the treatment of cystic fibrosis; 4D-175 that is in preclinical stage for treating geographic atrophy; 4D-725, which is in preclinical stage for the treatment of alpha-1 anti-trypsin deficiency lung disease; and 4D-310 that is in Phase 1 clinical trial for treating Fabry disease. 4D Molecular Therapeutics, Inc. has collaboration and licensing agreements with Astellas Gene Therapies, Inc.; Arbor Biotechnologies, Inc.; and uniQure biopharma B.V. The company was founded in 2013 and is headquartered in EmeryVille, California.
stock quote shares FDMT. – 4D Molecular Therapeutics Inc Stock Price stock today
news today FDMT. – 4D Molecular Therapeutics Inc stock forecast ,stock prediction 2023 2024 2025
marketwatch FDMT. – 4D Molecular Therapeutics Inc yahoo finance google finance
stock history FDMT. – 4D Molecular Therapeutics Inc invest stock market
stock prices FDMT premarket after hours
ticker FDMT fair value insiders trading